IMS HEALTH HLDGS INC (IMS) Stock Price, Quote, News and Overview
NYSE:IMS - New York Stock Exchange, Inc. -
IMS Quote, Performance and Key Statistics
31.34
+0.99 (+3.26%)
The current stock price of IMS is 31.34 null. In the past month the price increased by 4.99%. In the past year, price increased by 6.24%.
About IMS
Company Profile
IMS Health Holdings, Inc. engages in providing information, services, and technology to the healthcare industry worldwide. The company develops healthcare measurement solutions, such as IMS LifeLink program, IMS NPA Market Dynamics, IMS Xponent Prescribing Dynamics, IMS PlanTrak Market Dynamics, and Specialty Market Dynamics. It serves pharmaceutical, payers, government, providers, pharmacies, consumer health, pharmaceutical distribution, and financial community sectors. The company also provides consumer health insights, forecasting solutions, payer insights, pharmaceutical measurement solutions, and publications. IMS Health Holdings, Inc. is based in Danbury, Connecticut.
Company Info
IMS HEALTH HLDGS INC
83 WOOSTER HEIGHTS ROAD
DANBURY CT 06810
CEO: Ari Bousbib
Phone: 203-448-4600
IMS HEALTH HLDGS INC / IMS FAQ
What is the stock price of IMS HEALTH HLDGS INC today?
The current stock price of IMS is 31.34 null. The price increased by 3.26% in the last trading session.
What is the ticker symbol for IMS HEALTH HLDGS INC stock?
The exchange symbol of IMS HEALTH HLDGS INC is IMS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is IMS stock listed?
IMS stock is listed on the New York Stock Exchange, Inc. exchange.
What is IMS HEALTH HLDGS INC worth?
IMS HEALTH HLDGS INC (IMS) has a market capitalization of 10.32B null. This makes IMS a Large Cap stock.
What are the support and resistance levels for IMS HEALTH HLDGS INC (IMS) stock?
IMS HEALTH HLDGS INC (IMS) has a support level at 30.63 and a resistance level at 31.35. Check the full technical report for a detailed analysis of IMS support and resistance levels.
Should I buy IMS HEALTH HLDGS INC (IMS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IMS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IMS, evaluating the profitability, health, valuation and growth aspects
- IMS HEALTH HLDGS INC (IMS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- IMS HEALTH HLDGS INC (IMS) Sales and EPS estimates to see what analysts future expectations are.
- IMS HEALTH HLDGS INC (IMS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- IMS HEALTH HLDGS INC (IMS) Insider and Institutional Ownership to learn about the owners and their transactions.
- IMS HEALTH HLDGS INC (IMS) Stock Chart to make your own analysis
- IMS HEALTH HLDGS INC (IMS) Latest news and press-releases to stay up to date.
Does IMS HEALTH HLDGS INC (IMS) stock pay dividends?
IMS does not pay a dividend.
What is the Price/Earnings (PE) ratio of IMS HEALTH HLDGS INC (IMS)?
The PE ratio for IMS HEALTH HLDGS INC (IMS) is 74.62. This is based on the reported non-GAAP earnings per share of 0.42 and the current share price of 31.34 null. Check the full fundamental report for a full analysis of the valuation metrics for IMS.
IMS Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to IMS. When comparing the yearly performance of all stocks, IMS is one of the better performing stocks in the market, outperforming 75.44% of all stocks.
IMS Financial Highlights
Over the last trailing twelve months IMS reported a non-GAAP Earnings per Share(EPS) of 0.42. The EPS increased by 8.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 130.11% | ||
| ROA | 6.51% | ||
| ROE | 30.61% | ||
| Debt/Equity | 71.67 |